Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Other3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03923257Phase 1/2Withdrawn
Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents
Neuroendocrine TumorsParagangliomaPheochromocytoma
PrincipalinvestigatorStart date: 2020-08-04
NCT03335670Early Phase 1Active Not Recruiting
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
Neuroendocrine Tumors
PrincipalinvestigatorStart date: 2017-11-03
NCT03273712Phase 2Completed
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
MedulloblastomaMeningiomaNeuroblastoma+1 more
PrincipalinvestigatorStart date: 2017-09-29
NCT02194452Not ApplicableWithdrawn
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yusuf Menda, MD

University of Iowa

Related
2 trials

Shared therapeutic areas:

Neuroendocrine Tumors

Worked with same sponsors:

Holden Comprehensive Cancer CenterNational Cancer Institute (NCI)+2 more
Collaborated on 1 trial
Similarity Score14%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Anaplastic Astrocytoma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

MeningiomaNeuroblastomaOligodendroglioma, Adult
Similarity Score1%

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

NeuroblastomaMedulloblastomaMeningioma
Similarity Score1%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Neuroendocrine TumorsMeningioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Andrea B Apolo, M.D.

National Cancer Institute (NCI)

Related
12 trials

Shared therapeutic areas:

ParagangliomaPheochromocytoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Lillian Siu, MD

Princess Margaret Cancer Centre

Related
12 trials

Shared therapeutic areas:

MeningiomaNeuroendocrine Tumors
Similarity Score1%

Naris Nilubol, M.D.

National Cancer Institute (NCI)

Related
10 trials

Shared therapeutic areas:

Neuroendocrine TumorsNeuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

NeuroblastomaNeuroendocrine Tumors
Similarity Score1%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score0%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03923257Phase 1/2PrincipalInvestigator

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Neuroendocrine TumorsParagangliomaPheochromocytoma
Withdrawn
NCT03335670Early Phase 1PrincipalInvestigator

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors
Active Not Recruiting
NCT03273712Phase 2PrincipalInvestigator

Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)

MedulloblastomaMeningiomaNeuroblastoma+1 more
Completed
NCT02194452Not ApplicablePrincipalInvestigator

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more
Withdrawn

All 4 trials loaded